top of page
About Cellmover

Cellmover is a pre-clinical stage immunotherapy company committed to optimizing the tools of the immune system, with a vision to broaden the application of immunotherapies for various cancers.

Our technology

Immunotherapy includes strategies to enhance immune cell activation in patients to better target cancer.

Cellmover has developed a library of peptides and nanobodies directed at specific proteins in T cells and NK cells.


By targeting these proteins, the peptides and nanobodies mediate increased survival and persistence of immune cells within the tumor microenvironment

innovasjon norge_edited_edited.png
bottom of page